Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.2)Information about joint procurementThe contract involves joint procurement
I.3)CommunicationAdditional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authorityEuropean institution/agency or international organisation
I.5)Main activityGeneral public services
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Medical and other services for current and prospective staff members of European Medicines Agency (EMA) and European Banking Authority (EBA).
Reference number: EMA/2017/02/FI.
II.1.2)Main CPV code85120000 Medical practice and related services
II.1.3)Type of contractServices
II.1.4)Short description:
Provision of medical and other services for the EMA and EBA current and prospective staff members in line with the Staff Regulations. Services include pre-employments, annual medicals, occupational health review, counselling/psychological/psychiatric examinations, management and processing of sick leave certificates, assessment to spend sick leave abroad and justify special leave due to family illness, invalidity cases, well-being and health and safety policies and seasonal flu vaccinations.
Other services comprise display screen equipment (DSE) assessments, medical advice for business travel, business continuity support, supply and storage of medicine for pandemic flu purposes, transfers of medical files, training to EMA and EBA staff on matters within the subject of the tender and any other services relevant to the subject of the tender.
II.1.5)Estimated total valueValue excluding VAT: 3 000 000.00 GBP
II.1.6)Information about lotsThis contract is divided into lots: no
II.2)Description
II.2.1)Title:
II.2.2)Additional CPV code(s)85121200 Medical specialist services
85121000 Medical practice services
85147000 Company health services
85121270 Psychiatrist or psychologist services
II.2.3)Place of performanceNUTS code: UKI12 Inner London - East
II.2.4)Description of the procurement:
See Internet address provided in Section I.3.
II.2.5)Award criteriaPrice is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated valueValue excluding VAT: 3 000 000.00 GBP
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 48
This contract is subject to renewal: yes
Description of renewals:
See Internet address provided in Section I.3.
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
See Internet address provided in Section I.3.
Section III: Legal, economic, financial and technical information
III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registersList and brief description of conditions:
See Internet address provided in Section I.3.
III.1.2)Economic and financial standingSelection criteria as stated in the procurement documents
III.1.3)Technical and professional abilitySelection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
See Internet address provided in Section I.3.
III.2.3)Information about staff responsible for the performance of the contract
Section IV: Procedure
IV.1)Description
IV.1.1)Type of procedureOpen procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing systemThe procurement involves the establishment of a framework agreement
Framework agreement with a single operator
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participateDate: 30/05/2017
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:Bulgarian, Czech, Danish, German, Greek, English, Spanish, Estonian, Finnish, French, Irish, Croatian, Hungarian, Italian, Lithuanian, Latvian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Swedish
IV.2.6)Minimum time frame during which the tenderer must maintain the tenderDuration in months: 9 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tendersDate: 01/06/2017
Local time: 10:00
Place:
European Medicines Agency, 30 Churchill Place, Canary Wharf, London, E14 5EU, UNITED KINGDOM.
Information about authorised persons and opening procedure:
Maximum of 1 representative per tenderer is permitted to be present at the opening. For security reasons, tenderers must register within the given deadline (please see the invitation to tender letter) to be allowed to attend the opening session.
Section VI: Complementary information
VI.1)Information about recurrenceThis is a recurrent procurement: yes
VI.2)Information about electronic workflowsElectronic invoicing will be accepted
VI.3)Additional information:
Please note only 1 tender per tenderer may be submitted.
VI.4)Procedures for review
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedurePrecise information on deadline(s) for review procedures:
You may submit any observations concerning the award procedure to the contracting authority indicated under heading I.1.
If you believe that there was maladministration, you may lodge a complaint to the European Ombudsman within 2 years of the date when you became aware of the facts on which the complaint is based (see http://www.ombudsman.europa.eu). Such complaint does not have as an effect either to suspend the time limit to launch an appeal or to open a new period for lodging an appeal.
Within 2 months of the notification of the award decision you may lodge an appeal to the body referred to in VI.4.1.
VI.4.4)Service from which information about the review procedure may be obtainedOfficial name: European Medicines Agency
Postal address: 30 Churchill Place
Town: London
Postal code: E14 5EU
Country: United Kingdom
E-mail:
info@ema.europa.euTelephone: +44 2036606000
Fax: +44 2036605555
Internet address: http://www.ema.europa.eu/ema/
VI.5)Date of dispatch of this notice:12/04/2017
